Chromogenex Technologies

Chromogenex Technologies Ltd is the UK’s leading developer and manufacturer of advanced light and laser technology systems for medical and cosmetic procedures. Since its establishment in 1986, Chromogenex has applied groundbreaking innovations in the laser industry to address dermatological and aesthetic challenges faced by medical professionals. Today, practitioners worldwide use Chromogenex products to deliver safe and effective non-invasive treatments for a variety of conditions. These currently include the treatment of vascular and pigmented lesions, psoriasis, vitiligo, and acne, as well as permanent hair removal, skin rejuvenation, and fat reduction. Innovation drives successful growth, and Chromogenex continues to focus on high-growth export markets such as Brazil, the Far East, India, and South Africa, as well as Europe and North America. Chromogenex forecasts its turnover to increase from £6.9 million this year to approximately £12 million. Despite a challenging economic environment, this sustained rapid growth follows the successful sales of iLipo, the best-selling weight loss product in the U.S. This safe, non-surgical fat reduction device was introduced to the North American market last July and already accounts for over 60% of the company's total sales. Significant annual investments in R&D enable Chromogenex to maintain its market-leading position. We continue to look ahead. Our new product offerings include the non-invasive facelift device launched last year and a new hair removal product expected to be released in 2012.